Jan Nelis

Co-Founder at Ariya Bio (to be incorporated) developing genome-engineered red cells to cure blood disorders. Molecular Health Science graduate from ETH Zürich.

[ETH Zürich @ETH]

Blutarmut gehört weltweit zu den häufigsten Erbkrankheiten. Die ETH-Forscherin Mandy Boontanrart hat nun einen vielversprechenden Ansatz für deren Behandlung entdeckt. 🧬✂️ #CRISPRCas #Genschere #Blutarmut @Innosuisse @snf_ch

Erfahren Sie mehr:👇 https://t.co/9JyHtKU8VF

[Jacob Corn @jcornlab]

#CRISPR #globinopathy therapies target fetal globin. But delta globin is closer to adult globin *and* is expressed at low levels throughout life.
@ETH_Entprenship
Fellow Mandy Boontanrart developed #geneediting "fix" for delta promoter! Finally out @eLife https://t.co/grwmgwe5Gc

[Jan Nelis @jnelisARY]

Our work at @AriyaBioGET has been featured in @GENbio. Find out what makes the "Delta Force" a promising strategy for therapy.

Thank you @KevinADavies, for this feature!

#genetherapy #crispr #globinopathy #geneediting

[Kevin Davies @KevinADavies]

Delta Force: Scientists Promote Novel Globin Genetic Therapy for Sickle Cell Disease
-- my interview for @GENbio with Mandy Boontanrart @ETH_en on her clever strategy to switch up delta globin to treat #sicklecelldisease #CRISPR, just published @eLife
https://t.co/0EvVndmDA4

[Kevin Davies @KevinADavies]

Delta Force: Scientists Promote Novel Globin Genetic Therapy for Sickle Cell Disease
-- my interview for @GENbio with Mandy Boontanrart @ETH_en on her clever strategy to switch up delta globin to treat #sicklecelldisease #CRISPR, just published @eLife
https://t.co/0EvVndmDA4

[Jan Nelis @jnelisARY]

@Louqz_ @PSLetsPlayDE Verkaufst du eine ?